AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 41 filers reported holding AXSOME THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,688,000 | -34.7% | 250,000 | -23.8% | 0.21% | -10.5% |
| Q3 2016 | $2,585,000 | +0.3% | 328,061 | -4.0% | 0.24% | -23.4% |
| Q2 2016 | $2,577,000 | -9.9% | 341,790 | +2.8% | 0.31% | -19.8% |
| Q1 2016 | $2,859,000 | -8.2% | 332,390 | -2.6% | 0.39% | +28.8% |
| Q4 2015 | $3,114,000 | – | 341,092 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |